Testing effectiveness (Phase 2)Ended earlyNCT06447506What this trial is testingLong-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.Who this might be right forDermatitis, Atopic GlaxoSmithKline 79
Not applicableActive Not RecruitingNCT05081557What this trial is testingAssess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic DermatitisWho this might be right forAtopic Dermatitis AbbVie 873
Early research (Phase 1)Looking for participantsNCT06564389What this trial is testingFIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsWho this might be right forHealthy ParticipantsAtopic Dermatitis Pfizer 119
Not applicableUnknownNCT05023668What this trial is testingChina Atopic Dermatitis Registry StudyWho this might be right forDermatitis, Atopic Peking University People's Hospital 10,000
Testing effectiveness (Phase 2)UnknownNCT04725136What this trial is testingSafety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic DermatitisWho this might be right forAtopic Dermatitis Kang Stem Biotech Co., Ltd. 96
Testing effectiveness (Phase 2)Study completedNCT02594098What this trial is testingSecukinumab for Treatment of Atopic DermatitisWho this might be right forAtopic Dermatitis Icahn School of Medicine at Mount Sinai 41
Post-approval studies (Phase 4)Looking for participantsNCT05042258What this trial is testingUsing Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic DermatitisWho this might be right forAtopic DermatitisSleep Disturbance Northwestern University 40
Early research (Phase 1)Looking for participantsNCT06934252What this trial is testingPhase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis PatientsWho this might be right forModerate-to-severe Atopic Dermatitis TRex Bio, Inc. 115
Post-approval studies (Phase 4)Study completedNCT04033367What this trial is testingSAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"Who this might be right forAtopic Dermatitis Sanofi 188
Post-approval studies (Phase 4)Study completedNCT00925730What this trial is testingOpen-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under OcclusionWho this might be right forAtopic Dermatitis Novartis 20
Testing effectiveness (Phase 2)Study completedNCT03568136What this trial is testingInvestigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic DermatitisWho this might be right forDermatitis, AtopicEczema, AtopicNeurodermatitis, Atopic GWT-TUD GmbH 22
Large-scale testing (Phase 3)Looking for participantsNCT06461897What this trial is testingAssess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis AbbVie 675
Testing effectiveness (Phase 2)Ended earlyNCT04990440What this trial is testingBermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic DermatitisWho this might be right forDermatitis, Atopic Janssen Research & Development, LLC 6
Post-approval studies (Phase 4)Study completedNCT00832585What this trial is testingStudy to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Rush University Medical Center 5
Large-scale testing (Phase 3)Active Not RecruitingNCT05882877What this trial is testingAssess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)Who this might be right forAtopic Dermatitis Amgen 2,621
Testing effectiveness (Phase 2)Study completedNCT03151148What this trial is testingTargeted Microbiome Transplant in Atopic DermatitisWho this might be right forAtopic Dermatitis (AD) National Institute of Allergy and Infectious Diseases (NIAID) 54
Large-scale testing (Phase 3)Study completedNCT05899816What this trial is testingA Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)Who this might be right forAtopic DermatitisModerate-to-severe Atopic Dermatitis Amgen 221
Not applicableActive Not RecruitingNCT05139836What this trial is testingAssess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World SettingWho this might be right forAtopic Dermatitis AbbVie 634
Testing effectiveness (Phase 2)Study completedNCT05470114What this trial is testingA Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe ADWho this might be right forAtopic Dermatitis LEO Pharma 13
Testing effectiveness (Phase 2)Study completedNCT04018027What this trial is testingStudy to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic DermatitisWho this might be right forPruritusAtopic Dermatitis Cara Therapeutics, Inc. 401